CDK4/6 inhibition is more active against the glioblastoma proneural subtype.

about

The Oncogenic Relevance of miR-17-92 Cluster and Its Paralogous miR-106b-25 and miR-106a-363 Clusters in Brain Tumors.

P2860

Q55136092-6A2E4897-EC46-49C3-A1B3-5A204F8F1BFF

P2860

CDK4/6 inhibition is more active against the glioblastoma proneural subtype.

Item

http://www.wikidata.org/entity/Q41548769

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

CDK4/6 inhibition is more active against the glioblastoma proneural subtype.

@en

type

Item

label

CDK4/6 inhibition is more active against the glioblastoma proneural subtype.

@en

prefLabel

CDK4/6 inhibition is more active against the glioblastoma proneural subtype.

@en

P1476

CDK4/6 inhibition is more active against the glioblastoma proneural subtype.

@en

P2093

Aizhen Xiao

http://www.w3.org/2001/XMLSchema#string

Benjamin Purow

http://www.w3.org/2001/XMLSchema#string

Desiree Floyd

http://www.w3.org/2001/XMLSchema#string

Erik P Sulman

http://www.w3.org/2001/XMLSchema#string

Ichiro Nakano

http://www.w3.org/2001/XMLSchema#string

Inan Olmez

http://www.w3.org/2001/XMLSchema#string

Jakub Godlewski

http://www.w3.org/2001/XMLSchema#string

Jeongwu Lee

http://www.w3.org/2001/XMLSchema#string

Krishna P L Bhat

http://www.w3.org/2001/XMLSchema#string

Ming Li

http://www.w3.org/2001/XMLSchema#string

P2860

PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro

An integrated genomic analysis of human glioblastoma multiforme

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

Pharmacologic inhibition of cyclin-dependent kinases 4 and 6 arrests the growth of glioblastoma multiforme intracranial xenografts.

Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

c-Myc-regulated microRNAs modulate E2F1 expression

MicroRNA expression profiles classify human cancers

The myc-miR-17~92 axis blunts TGF{beta} signaling and production of multiple TGF{beta}-dependent antiangiogenic factors

P304

55319-55331

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.19429

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Agnieszka Bronisz

P577

2017-07-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28903422

http://www.w3.org/2001/XMLSchema#string

P932

5589661

http://www.w3.org/2001/XMLSchema#string

CDK4/6 inhibition is more active against the glioblastoma proneural subtype.

about

P2860

P2860

CDK4/6 inhibition is more active against the glioblastoma proneural subtype.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932